{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:41:17Z","timestamp":1793482877133,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T00:00:00Z","timestamp":1587081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijid.2020.04.043","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T13:44:58Z","timestamp":1587735898000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Prediction of treatment outcomes for multidrug-resistant tuberculosis by whole-genome sequencing"],"prefix":"10.1016","volume":"96","author":[{"given":"Guiqing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.04.043_bib0005","series-title":"Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update","author":"WHO","year":"2016"},{"key":"10.1016\/j.ijid.2020.04.043_bib0010","unstructured":"Global Tuberculosis Report 2018. Geneva: World Health Organization; 2018."},{"key":"10.1016\/j.ijid.2020.04.043_bib0015","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1016\/S1473-3099(18)30104-X","article-title":"Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible?","volume":"18","author":"Cox","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ijid.2020.04.043_bib0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S1473-3099(16)30190-6","article-title":"Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project","volume":"16","author":"Zignol","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ijid.2020.04.043_bib0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","article-title":"Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues","volume":"17","author":"Meehan","year":"2019","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.ijid.2020.04.043_bib0030","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing","volume":"379","author":"Allix-Beguec","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ijid.2020.04.043_bib0035","first-page":"52","article-title":"Whole genome sequencing of Mycobacterium tuberculosis","author":"Cabibbe","year":"2018","journal-title":"Eur Respir J."},{"key":"10.1016\/j.ijid.2020.04.043_bib0040","unstructured":"Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. Geneva: World Health Organization; 2011."},{"key":"10.1016\/j.ijid.2020.04.043_bib0045","unstructured":"WHO revised definitions and reporting framework for tuberculosis. Euro Surveill. 2013; 18:20455."},{"key":"10.1016\/j.ijid.2020.04.043_bib0050","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3389\/fmicb.2019.01741","article-title":"Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol."},{"key":"10.1016\/j.ijid.2020.04.043_bib0055","series-title":"Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","author":"WHO","year":"2018"},{"key":"10.1016\/j.ijid.2020.04.043_bib0060","first-page":"53","article-title":"Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study","author":"Sun","year":"2019","journal-title":"Eur Respir J."},{"key":"10.1016\/j.ijid.2020.04.043_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.ijid.2020.04.043_bib0070","first-page":"D10705","article-title":"The diagnostic accuracy of the GenoType((R)) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs","author":"Theron","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ijid.2020.04.043_bib0075","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study","volume":"53","author":"Tagliani","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2020.04.043_bib0080","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/cid\/cix556","article-title":"Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study","volume":"65","author":"Farhat","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2020.04.043_bib0085","first-page":"D4795","article-title":"Fluoroquinolones for treating tuberculosis","author":"Ziganshina","year":"2008","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ijid.2020.04.043_bib0090","series-title":"Treatment Guidelines for Drug-Resistant Tuberculosis, 2018 Update","author":"WHO","year":"2018"},{"key":"10.1016\/j.ijid.2020.04.043_bib0095","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(18)31644-1","article-title":"Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"392","author":"Ahmad","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.ijid.2020.04.043_bib0100","first-page":"49","article-title":"Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance","author":"Van Deun","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.ijid.2020.04.043_bib0105","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1038\/s41598-019-48289-9","article-title":"Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations","volume":"9","author":"Rigouts","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.ijid.2020.04.043_bib0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JCM.02775-15","article-title":"Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis","volume":"54","author":"Farhat","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2020.04.043_bib0115","doi-asserted-by":"crossref","first-page":"e39754","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations","volume":"7","author":"Malik","year":"2012","journal-title":"Plos One."},{"key":"10.1016\/j.ijid.2020.04.043_bib0120","unstructured":"Companion Handbook to the WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2014."},{"key":"10.1016\/j.ijid.2020.04.043_bib0125","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1365-2672.2010.04840.x","article-title":"Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugs","volume":"109","author":"Leung","year":"2010","journal-title":"J Appl Microbiol."},{"key":"10.1016\/j.ijid.2020.04.043_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","article-title":"Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study","volume":"4","author":"Pankhurst","year":"2016","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.ijid.2020.04.043_bib0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.3548","article-title":"Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance","volume":"48","author":"Desjardins","year":"2016","journal-title":"Nat Genet."},{"key":"10.1016\/j.ijid.2020.04.043_bib0140","first-page":"56","article-title":"Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing","author":"Doyle","year":"2018","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220302605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220302605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:50:23Z","timestamp":1761119423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220302605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"alternative-id":["S1201971220302605"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.04.043","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of treatment outcomes for multidrug-resistant tuberculosis by whole-genome sequencing","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}